Aptamers targeting SARS-CoV-2 nucleocapsid protein exhibit potential anti pan-coronavirus activity

Minghui Yang(Lanzhou University of Technology), Yongxiang Zhao(Guangxi Medical University), Guoguo Ye(Southern University of Science and Technology), Pengfei Wu(Huazhong University of Science and Technology), Yingxia Liu(Southern University of Science and Technology), Abid Hussain(Beijing Institute of Technology), Yuanyu Huang(Beijing Institute of Technology), Lu Gan(University of Virginia), Yuhua Weng(Xiamen University), Chenguang Shen(Southern Medical University), Tian Zhang(National Institute of Biological Sciences, Beijing), Chunhui Li(Beijing Institute of Technology), Jun Yang(Wuhan Third Hospital), Yuxin Tian(Beijing Institute of Technology), Zhimin Wang(Beijing Institute of Technology), Mengyuan Zhao(Chinese Academy of Sciences), Ge Yang(Shandong University of Technology), Liping Zhong(Guangxi Medical University), Xinyue Liu(Beijing Institute of Technology), Haiyin Yang(Beijing Institute of Technology), Qianyu Zhang(Guangxi Medical University), Huiping Shi(Oklahoma Medical Research Foundation)
Signal Transduction and Targeted Therapy
February 14, 2024
Cited by 28


Related Papers